首页 > 市场调查报告书 > 食物/饮料

机能性食品益生菌

市场调查报告书

商品编码

1512676

全球双歧桿菌益生菌市场 - 2024-2031

Global Bifidobacterium Probiotic Market - 2024-2031

出版日期: 2024年07月10日 | 出版商:

DataM Intelligence | 英文 213 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

全球双歧桿菌益生菌市场将于 2023 年达到 11 亿美元，预计到 2031 年将达到 19 亿美元，2024-2031 年预测期间复合年增长率为 8.8%。

消费者越来越意识到肠道健康的重要性以及包括双歧桿菌在内的益生菌在维持肠道健康方面的作用。这种意识的提高正在推动不同人群对益生菌产品的需求，从而推动市场成长。製造商正在使其产品多样化，以满足不同消费者的喜好和需求，为消费者提供更多选择，将益生菌融入日常生活中。

例如，2023 年 5 月 23 日，PanTheryx 的益生菌补充剂品牌 TruBiotics 推出了两款专为解决女性健康各个方面问题而量身定制的新补充剂。这些胶囊的配方包含益生菌菌株的组合，这些益生菌菌株因其在促进消化和阴道健康方面的功效而闻名。这些菌株中包括动物双歧桿菌，它被认为是研究最广泛的消化健康有益细菌之一。

随着消费者健康意识的增强，人们对包括双歧桿菌益生菌在内的益生菌产品越来越感兴趣，以支持亚太地区的消化健康和整体福祉。亚太地区的公司正在投资研发，探索益生菌的健康益处并开发创新产品。这包括研究双歧桿菌益生菌在解决该地区普遍存在的特定健康状况方面的功效。

动力学

提高消费者对肠道健康的认识

随着越来越多的人认识到维持健康的肠道微生物群对整体健康的重要性，对益生菌补充剂和含有双歧桿菌的食品的需求不断增长。这种意识的提高促使消费者寻找能够改善消化健康、增强免疫力和增强整体健康的产品，从而扩大了市场。

公司向消费者宣传双歧桿菌益生菌益处的行销努力也发挥着至关重要的作用。透过强调对肠道健康的正面影响，这些活动吸引了更大的客户群。因此，在知情且具有健康意识的消费者群体的推动下，全球双歧桿菌益生菌市场正在经历显着成长。

例如，2023年10月10日，一家以生产跳跳糖为主食而闻名的广东公司透过加入功能性成分来提高营养价值，从而创新了其产品线。该公司在竞争激烈的市场上推出了一系列注入维生素 C 和益生菌（特别是双歧桿菌）的新糖果。

该公司传统上以其跳跳糖产品而闻名，现在它正在利用其製造技术来创造一种富含促进健康成分的新颖糖果体验。透过将维生素 C 和双歧桿菌益生菌融入糖果配方中，该公司旨在为消费者提供一种方便、愉快的方式来增强免疫系统和支持消化健康。

对天然和有机产品的偏好日益增长

对天然和有机产品日益增长的偏好是推动全球双歧桿菌益生菌市场的主要因素。随着消费者越来越多地寻求更健康、更永续的选择，他们开始转向天然和有机益生菌来增强肠道健康。这种趋势在註重健康的个人中尤其强烈，他们更喜欢不含合成添加剂和防腐剂的产品。

为了满足这一需求，市场上的製造商正在专注于开发符合天然和有机标准的双歧桿菌益生菌。这种转变不仅吸引了更广泛的客户群，也鼓励市场内的创新和产品多样化。因此，对天然和有机产品的偏好极大地促进了全球双歧桿菌益生菌市场的扩张和成长。

例如，2022年4月28日，中国乳製品巨头伊利推出了最新的产品发布策略，重点介绍创新产品，以满足不断变化的消费者喜好。其中一项策略是推出富含益生菌和 GABA 作为主要成分的固体饮料。虽然伊利已在乳製品市场建立了强大的影响力，特别是在优格、起司和冰淇淋等益生菌产品方面，但这次进军固体饮料的新业务标誌着其产品组合的战略扩张。

严格的监管框架

严格的监管框架是全球双歧桿菌益生菌市场的重大限制。不同地区的监管机构对益生菌产品的批准、标籤和行销制定了严格的指导方针，以确保安全性和有效性。这些法规通常需要广泛的临床试验和科学证据来证实健康声明，这对製造商来说可能既昂贵又耗时。

因此，规模较小的公司面临进入壁垒，甚至市场上的老牌企业也可能会遇到产品发布延迟和额外的合规成本。这种监管负担可能会限制新双歧桿菌益生菌产品的上市速度，也会减少消费者可获得的产品种类。严格的监管框架是一个重大限制，影响着全球双歧桿菌益生菌市场的成长和扩张。

例如，2023 年12 月27 日，监管机构最近收到了一份令人担忧的不良事件报告，涉及一名早产儿，该婴儿接受益生菌Evivo 和MCT 油（婴儿健康）治疗，作为预防坏死性小肠结肠炎的住院护理的一部分。不幸的是，在服用 Evivo 后，患者因 Evivo 中存在的长双歧桿菌而出现败血症，并随后死亡。该事件是早产儿在接受作为疾病预防措施销售的益生菌后出现不良事件的几起报告案例之一。

There is increasing awareness among consumers about the importance of gut health and the role of probiotics, including bifidobacterium, in maintaining it. This heightened awareness is driving demand for probiotic products across various demographics, fueling market growth. Manufacturers are diversifying their product offerings to cater to different consumer preferences and needs, providing consumers with more options to incorporate probiotics into their daily routines.

For instance, on May 23, 2023, PanTheryx's probiotic supplements brand, TruBiotics, introduced two new supplements tailored to address various aspects of women's health. The formulation of these capsules includes a combination of probiotic strains known for their efficacy in promoting digestive and vaginal health. Among these strains is Bifidobacterium animalis, recognized as one of the most extensively researched beneficial bacteria for digestive well-being.

As consumers become more health-conscious, there is a growing interest in probiotic products, including bifidobacterium probiotics, to support digestive health and overall well-being in the Asia-Pacific. Companies in the Asia-Pacific region are investing in research and development to explore the health benefits of probiotics and develop innovative products. This includes studying the efficacy of bifidobacterium probiotics in addressing specific health conditions prevalent in the region.

Dynamics

Increasing Consumer Awareness About Gut Health

As more people recognize the importance of maintaining a healthy gut microbiome for overall well-being, there is a growing demand for probiotic supplements and foods that contain bifidobacterium. This heightened awareness is prompting consumers to seek out products that can improve digestive health, boost immunity, and enhance overall wellness, thus expanding the market.

Marketing efforts by companies to educate consumers about the benefits of bifidobacterium probiotics are also playing a crucial role. By highlighting the positive effects on gut health, these campaigns are attracting a larger customer base. As a result, the global bifidobacterium probiotic market is experiencing significant growth, driven by an informed and health-conscious consumer population.

For instance, on October 10, 2023, A Guangdong-based company, known for its expertise in producing popping candy as a staple food item, innovated its product line by incorporating functional ingredients to enhance nutritional value. The company has introduced a new range of candy infused with vitamin C and probiotics, specifically Bifidobacterium in the competitive market.

Traditionally recognized for its popping candy offerings, the company is leveraging its manufacturing techniques to create a novel candy experience enriched with health-promoting ingredients. By incorporating vitamin C and Bifidobacterium probiotics into the candy formulation, the company aims to provide consumers with a convenient and enjoyable way to boost their immune system and support digestive health.

Growing Preference for Natural and Organic Products

The growing preference for natural and organic products is a major factor driving the global bifidobacterium probiotic market. As consumers increasingly seek healthier and more sustainable options, they are turning to natural and organic probiotics to enhance their gut health. This trend is particularly strong among health-conscious individuals who prefer products free from synthetic additives and preservatives.

In response to this demand, manufacturers in the market are focusing on developing bifidobacterium probiotics that align with natural and organic standards. This shift is not only attracting a broader customer base but also encouraging innovation and product diversification within the market. Consequently, the preference for natural and organic products is significantly contributing to the expansion and growth of the global bifidobacterium probiotic market.

For instance, on April 28, 2022, China's dairy powerhouse, Yili, launched its latest product launch strategies, focusing on the introduction of innovative offerings to meet evolving consumer preferences. Among these strategies is the debut of a solid beverage enriched with probiotics and GABA as its primary ingredients. While Yili has established a strong presence in the dairy market, particularly with probiotic-infused products like yogurt, cheese, and ice cream, this new venture into solid beverages marks a strategic expansion of its product portfolio.

Stringent Regulatory Frameworks

Stringent regulatory frameworks are a significant restraint on the global bifidobacterium probiotic market. Regulatory bodies across different regions impose strict guidelines on the approval, labeling, and marketing of probiotic products to ensure safety and efficacy. These regulations often require extensive clinical trials and scientific evidence to substantiate health claims, which can be costly and time-consuming for manufacturers.

As a result, smaller companies face barriers to entry, and even established players in the market might experience delays in product launches and additional compliance costs. This regulatory burden can limit the speed at which new bifidobacterium probiotic products are brought to market and can also reduce the variety of products available to consumers. Stringent regulatory frameworks act as a significant constraint, impacting the growth and expansion of the global bifidobacterium probiotic market.

For instance, on December 27, 2023, The regulatory agency recently received a concerning adverse event report concerning a preterm infant who received treatment with the probiotic Evivo with MCT Oil (Infinant Health) as part of in-hospital care to prevent necrotizing enterocolitis. Tragically, following the administration of Evivo, the patient developed sepsis, attributed to the bacterium Bifidobacterium longum present in Evivo, and subsequently succumbed. This incident is among several reported cases where preterm infants experienced adverse events after receiving probiotics marketed as preventive measures against the disease.

Segment Analysis

The global bifidobacterium probiotic market is segmented based on type, form, application, end-user, and region.

Growing Innovations and Consumer Preference for Bifidobacterium longum

Consumers are increasingly seeking out probiotic products containing specific strains like Bifidobacterium longum due to their perceived health benefits and efficacy. This consumer preference drives demand for products containing this strain, contributing to its dominant position in the market. Bifidobacterium longum is commonly used in a variety of probiotic products. Its versatility and proven efficacy make it an attractive option for manufacturers looking to develop probiotic formulations to meet diverse consumer needs.

Bifidobacterium longum is one of the most extensively studied probiotic strains, with numerous clinical studies supporting its efficacy in promoting gut health and overall well-being. This robust scientific evidence enhances consumer confidence in the effectiveness of products containing Bifidobacterium longum, driving market demand. Companies often highlight the inclusion of Bifidobacterium longum in their products as a key selling point, leveraging its well-established reputation and positive consumer perception to drive sales and capture market share.

Geographical Penetration

Strong Tradition of Fermented Foods and Investments in Asia-Pacific

The Asia-Pacific region has a significant portion of the world's population, including densely populated countries like China and India. Many countries in the Asia-Pacific region have a long tradition of consuming fermented foods like yogurt, kimchi, and miso, which naturally contain probiotics. This cultural familiarity with probiotic-rich foods contributes to the growing acceptance and demand for bifidobacterium probiotics in the region.

Governments, academic institutions, and private companies in the Asia-Pacific region are investing heavily in research and development to explore the health benefits of probiotics and develop innovative products. This focus on innovation and product development is driving market growth and strengthening the region's position in the global bifidobacterium probiotic market.

COVID-19 Impact Analysis

The COVID-19 pandemic had a notable impact on the global bifidobacterium probiotic market. During the pandemic, there was a heightened focus on health and wellness, leading to increased consumer interest in products that support immune function and overall health, including bifidobacterium probiotics. This surge in demand positively influenced the market, as more individuals sought probiotics to boost their immunity and maintain gut health during a time of increased health awareness.

However, the market also faced challenges due to COVID-19. Supply chain disruptions and logistical issues caused delays in the production and distribution of probiotic products. Additionally, economic uncertainties led to cautious consumer spending, affecting the market's growth rate. Despite these challenges, the overall impact of COVID-19 has been a renewed emphasis on preventive health measures, which is likely to sustain the market's growth in the long term as consumers continue to prioritize their health post-pandemic.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine war has indirect effects on the global bifidobacterium probiotic market due to potential disruptions in the supply chain and geopolitical instability. Ukraine is a significant producer of grains, including wheat, which is a key ingredient in animal feed. Bifidobacterium probiotics are commonly used in animal feed to promote gut health and improve overall livestock health.

Disruptions in the Ukrainian grain market could lead to fluctuations in feed prices, affecting the livestock industry worldwide. This, in turn, may impact the demand for bifidobacterium probiotics, as farmers adjust their purchasing decisions based on feed costs. Geopolitical tensions and economic sanctions imposed on Russia and Ukraine could disrupt trade routes and distribution channels for bifidobacterium probiotic products.

By Type

Bifidobacterium animalis
Bifidobacterium longum
Bifidobacterium bifidum
Others

By Form

Dry
Liquid

By Application

Food & Beverages
Dietary Supplements
Pharmaceuticals
Animal Feed
Others

By End-User

Infants
Adults
Children
Animals

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

On January 30, 2023, Nissin Foods Group, announced the launch of Foods with Function Claims (FFCs) featuring lactic acid bacteria for the first time. This innovative move reflects the company's commitment to staying at the forefront of evolving consumer preferences and trends, particularly in the realm of gut health and the gut-brain axis.
On March 1, 2021, Bayer expanded its portfolio beyond gastrointestinal relief to address overall gut health with the introduction of two new probiotic products. Developed in collaboration with China's Jiangnan University, these probiotics are specifically formulated to target common gastrointestinal issues, including constipation and diarrhea.
On June 16, 2020, Yakult Japan introduced its inaugural shelf-stable probiotic supplement, marking a significant expansion in its product offerings. Packed into convenient sachets, this supplement contains two exclusive probiotic strains: the renowned lactic acid bacteria, Lactobacillus casei strain Shirota, and the beneficial bifidobacteria, Bifidobacterium breve strain Yakult.

Competitive Landscape

The major players in the global bifidobacterium probiotic market include DuPont, Goerlich Pharma GmbH, Mitushi Bio Pharma, and Chr. Hansen Holding A/S, Probi AB, Lallemand Inc., Novozymes A/S, Danone Corp, Nestle S.A., Yakult Honsha Co., Ltd.

Why Purchase the Report?

To visualize the global bifidobacterium probiotic market segmentation based on type, form, application, end-user, and region and understand critical commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous global streptococcus probiotic market-level data points with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of critical products of all the major players.

The global bifidobacterium probiotic market report would provide approximately 70 tables, 65 figures, and 213 users.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Form
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Consumer Awareness About Gut Health
  - 4.1.1.2. Growing Preference for Natural and Organic Products
- 4.1.2. Restraints
  - 4.1.2.1. Stringent Regulatory Frameworks
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. Bifidobacterium animalis*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Bifidobacterium longum
7.4. Bifidobacterium bifidum
7.5. Others

8. By Form

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 8.1.2. Market Attractiveness Index, By Form
8.2. Dry*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Liquid

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Food & Beverages*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Dietary Supplements
9.4. Pharmaceuticals
9.5. Animal Feed
9.6. Others

10. By End-User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2. Market Attractiveness Index, By End-User
10.2. Infants*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Adults
10.4. Children
10.5. Animals

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. UK
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Russia
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. DuPont*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Goerlich Pharma GmbH
13.3. Mitushi Bio Pharma
13.4. Chr. Hansen Holding A/S
13.5. Probi AB
13.6. Lallemand Inc.
13.7. Novozymes A/S
13.8. Danone Corp
13.9. Nestle S.A.
13.10. Yakult Honsha Co., Ltd.

LIST NOT EXHAUSTIVE